F. Aoki

F. Aoki, S. Mubareka, J. Papenburg, 2019, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

Use of antiviral prophylaxis in influenza outbreaks in long term care facilities.

F. Aoki, A. McGeer, D. Sitar, 2000, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Treatment of wounds from animals suspected of carrying neurotropic viruses.

L. Klenerman, F. Aoki, C. Coid, 1975, British medical journal.

Guidance for practitioners on the use of antiviral drugs to control influenza outbreaks in long-term care facilities in Canada, 2014–2015 season

D. Skowronski, F. Aoki, H. Stiver, 2015, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine

F. Aoki, D. Sitar, D. Smyth, 1993, Clinical pharmacology and therapeutics.

Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.

F. Aoki, 2003, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine

F. Aoki, S. Halperin, E. Rubinstein, 2011, Canadian Medical Association Journal.

Famciclovir: a focus on efficacy and safety

F. Aoki, D. Vinh, S. Mubareka, 2010, Expert opinion on drug safety.

Clinical Pharmacokinetics of Amantadine Hydrochloride

F. Aoki, D. Sitar, 1988, Clinical pharmacokinetics.

Amantadine kinetics in healthy young subjects after long‐term dosing

F. Aoki, R. Ogilvie, D. Sitar, 1979, Clinical pharmacology and therapeutics.

Immunization against influenza and pneumococcal disease in residents of long term care facilities.

F. Aoki, 1996, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Amantadine prophylaxis during an institutional outbreak of type A influenza.

F. Aoki, D. Sitar, 1987, Archives of Internal Medicine.

Potential of Influenza Vaccine and Amantadine to Prevent Influenza A Illness in Canadian Forces Personnel 1980–1983

F. Aoki, C. Vermeersch, H. Stiver, 1986, Military medicine.

Urine specimen collection with external devices for diagnosis of bacteriuria in elderly incontinent men

F. Aoki, L. Nicolle, G. Harding, 1988, Journal of clinical microbiology.

45 – Antivirals against Herpes Viruses

F. Aoki, 2015 .

Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine.

F. Aoki, D. Bernstein, G. Leroux-Roels, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nadolol antihypertensive effect and disposition in young and elderly adults with mild to moderate essential hypertension

F. Aoki, D. Sitar, S. Penner, 1989, Clinical pharmacology and therapeutics.

Guidance on the use of antiviral agents for the 2019-2020 influenza season.

D. Skowronski, F. Aoki, S. Mubareka, 2020, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis

R. Schooley, M. Hirsch, D. Hanley, 2005, Infection.

Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.

F. Aoki, S. Tyring, K. Hamed, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunization with a human diploid cell strain of rabies virus vaccine: two-year results.

F. Aoki, K. Nicholson, G. Turner, 1978, The Journal of infectious diseases.

Amantadine acetylation may be effected by acetyltransferases other than NAT1 or NAT2.

F. Aoki, D. Sitar, A. Bras, 1998, Canadian journal of physiology and pharmacology.

Chronic tobacco smoking and gender as variables affecting amantadine disposition in healthy subjects.

F. Aoki, D. Sitar, L. Wong, 1995, British journal of clinical pharmacology.

2020-2021 AMMI Canada guidance on the use of antiviral drugs for influenza in the setting of co-circulation of seasonal influenza and SARS-CoV-2 viruses in Canada.

F. Aoki, S. Mubareka, J. Papenburg, 2020, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects.

F. Aoki, J. Saunders, A. Friesen, 1989, Journal of biological standardization.

Long‐Term Captopril in Young and Old Patients with Mild Hypertension

F. Aoki, D. Sitar, S. Penner, 1991, Journal of clinical pharmacology.

Oseltamivir: a clinical and pharmacological perspective

F. Aoki, K. Doucette, Fred Y Aoki, 2001, Expert opinion on pharmacotherapy.

Early administration of oral oseltamivir increases the benefits of influenza treatment.

F Y Aoki, O. Carewicz, P. Ward, 2003, The Journal of antimicrobial chemotherapy.

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections

Leming, F. Hayden, F. Aoki, 1997 .

Prospective, randomized, comparative trials in the therapy for intraabdominal and female genital tract infections.

F. Aoki, L. Nicolle, H. Stiver, 1984, Reviews of infectious diseases.

Respiratory failure in a man with bone and lung lesions.

E. Hershfield, F. Aoki, J. Embil, 1998, Hospital practice.

Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective

F. Aoki, D. Vinh, 2006, Expert opinion on pharmacotherapy.

Antiviral Drugs (Other than Antiretrovirals)

F. Hayden, F. Aoki, R. Dolin, 2010 .

Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial

F. Aoki, R. Belshe, M. Dionne, 2013, International journal of STD & AIDS.

Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy.

D. Hanley, F. Aoki, P. Griffiths, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vidarabine versus acyclovir therapy in herpes simplex encephalitis.

R. Schooley, M. Hirsch, D. Hanley, 1986, The New England journal of medicine.

Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.

F. Aoki, S. Shafran, S. Sacks, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomized, Double-Blind, Placebo-Controlled, Clinic-Initiated, Canadian Multicenter Trial of Topical Edoxudine 3.0% Cream in the Treatment of Recurrent Genital Herpes

J. Singer, F. Aoki, M. Gill, 1991 .

Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial.

F. Aoki, D. Tyrrell, M. Gill, 1997, The Journal of infectious diseases.

Effect of acute experimental influenza a virus pneumonia on concentration of alpha1-acid glycoprotein in mouse serum

F. Aoki, R. Weselake, D. Sitar, 1989, Inflammation.

Partial characterization of alpha 1-acid glycoprotein isolated from mouse serum.

F. Aoki, R. Weselake, B. Peltz, 1987, Comparative biochemistry and physiology. B, Comparative biochemistry.

Comparative Efficacy of Famciclovir and Valacyclovir for Suppression of Recurrent Genital Herpes and Viral Shedding

F. Aoki, A. Wald, L. Corey, 2006, Sexually transmitted diseases.

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, The Lancet. Oncology.

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, The Lancet. Oncology.

A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma.

F. Aoki, R. Grossman, D. Sitar, 1993, Chest.

Pharmacokinetics and pharmacodynamics of bambuterol, a long‐acting bronchodilator pro‐drug of terbutaline, in young and elderly patients with asthma

F. Aoki, D. Sitar, C. P. Warren, 1992, Clinical pharmacology and therapeutics.

HUMAN DIPLOID CELL STRAIN RABIES VACCINE Rapid Prophylactic Immunisation of Volunteers with Small Doses

F. Aoki, K. Nicholson, D. Tyrrell, 1976, The Lancet.

Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine

F. Aoki, B. Oberg, A. Ericson, 1985, Antimicrobial Agents and Chemotherapy.

Distribution and Retention of Human Serum Albumin—Technetium-99m Instilled Intranasally by Drops and Spray

F. Aoki, J. Crawley, 1976 .

Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.

F. Aoki, D. Rosenthal, J. Portnoy, 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial.

F. Aoki, D. Tyrrell, W. Schlech, 1987, The Journal of infectious diseases.

Intracerebroventricular and intraperitoneal disodium phosphonoacetate treatment of herpes simplex virus type I experimental encephalitis in rats.

F. Aoki, G. Trépanier, G. Lussier, 1979, The Journal of infectious diseases.

A Comparison of the Antiherpes Activities in Vitro and in Vivo of Foscarnet and Mono- and Dihydroxybutylguanine

F. Aoki, A. Ericson, A. Larsson, 1985 .

Antiviral Drugs for Influenza and Other Respiratory Virus Infections

F. Aoki, 2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases.

Effect of a polynucleotide interferon inducer of fungal origin on experimental rhinovirus infection in humans.

F. Aoki, D. Tyrrell, S. Reed, 1978, The Journal of infectious diseases.

Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial

C. Wheeler, H. Kitchener, M. Lehtinen, 2015, Clinical and Vaccine Immunology.

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

C. Wheeler, D. Harper, A. Moscicki, 2009, The Lancet.

Pharmacokinetic Disposition of Loracarbef in Healthy Young Men and Women at Steady State

F. Aoki, D. Hoban, D. Sitar, 1994, Journal of clinical pharmacology.

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

F Y Aoki, S. Trottier, O. Carewicz, 2000, Lancet.

The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013.

F. Aoki, H. Stiver, G. Evans, 2012, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Glycoprotein-D-adjuvant vaccine to prevent genital herpes.

F. Aoki, D. Bernstein, L. Stanberry, 2002, The New England journal of medicine.

Severe Acute Respiratory Syndrome-Related Coronavirus Is Inhibited by Interferon-α

F. Aoki, J. Strong, H. Feldmann, 2004, The Journal of infectious diseases.

Naturally acquired serum rabies neutralizing antibody in a Canadian Inuit population.

F. Aoki, P. H. Orr, M. R. Rubin, 1988, Arctic medical research.

Rabies neutralizing antibody in serum of children compared to adults following post-exposure prophylaxis.

F. Aoki, M. Fast, M. Rubin, 1992, Biologicals : journal of the International Association of Biological Standardization.

Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, International journal of cancer.

Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization

F. Aoki, D. Tyrrell, K. Nicholson, 1982, Journal of Hygiene.

Influenza virus shedding: excretion patterns and effects of antiviral treatment.

F. Aoki, G. Boivin, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Influenza Virus Susceptibility and Resistance to Oseltamivir

F. Aoki, G. Boivin, N. Roberts, 2005, Antiviral therapy.

Zanamivir and Polymeric Zanamivir Conjugates

F. Aoki, 2010 .

2021-2022 AMMI Canada guidance on the use of antiviral drugs for influenza in the COVID-19 pandemic setting in Canada.

F. Aoki, S. Mubareka, J. Papenburg, 2022, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

Drug‐Associated Hospital Admissions in Older Medical Patients

F Y Aoki, F. Aoki, P. Montgomery, 1988, Journal of the American Geriatrics Society.

Acyclovir Bioavailability in Patients With Acute Myelogenous Leukemia Treated With Daunorubicin and Cytarabine

F. Aoki, E. Bow, D. Sitar, 2008, Journal of clinical pharmacology.

Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.

F. Aoki, D. Sitar, A. P. Bras, 2001, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.

Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial

D. Earn, R. Webby, S. Walter, 2016, PloS one.

Severe lithium intoxication: management without dialysis and report of a possible teratogenic effect of lithium.

F. Aoki, J. Ruedy, 1971, Canadian Medical Association journal.

Influenza immunization: knowledge, attitude and behaviour of health care workers.

F. Aoki, M. Cheang, A. Yassi, 1994, The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections.

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

D M Fleming, K G Nicholson, F Y Aoki, 1997, The New England journal of medicine.

Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals

F. Aoki, B. Romanowski, R. Saltzman, 2000 .

Neonatal herpes simplex virus infection in Manitoba, 1980 to 1986, and implications for preventive strategies.

F. Aoki, G. Hammond, L. Selin, 1988, The Pediatric infectious disease journal.

Pseudomonas folliculitis in a resort whirlpool.

D Maguire, F Y Aoki, J A Eadie, 1982, Canadian Medical Association journal.

Double-blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy.

F. Aoki, R. Ogilvie, R. Seymour, 1983, Surgery.

Impact of Zanamivir Treatment on Productivity, Health Status and Healthcare Resource Use in Patients with Influenza

D. Fleming, F. Aoki, L. Lacey, 2000, PharmacoEconomics.

Enprofylline disposition in the presence and absence of amoxycillin or erythromycin.

F. Aoki, D. Hoban, D. Sitar, 1987, British journal of clinical pharmacology.

Slow release theophylline disposition and effect in elderly patients with chronic obstructive lung disease: influence of dose formulation and institutionalization.

F. Aoki, D. Sitar, P. Mitenko, 1989, Biopharmaceutics & drug disposition.

Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA

C. Wheeler, H. Kitchener, M. Lehtinen, 2014, The Journal of infectious diseases.

In vitro reactivation of latent herpes simplex virus by the demethylating compound hexamethylene-bis-acetamide.

F. Aoki, J. Blondeau, 1992, Journal of Virological Methods.

The use of antiviral drugs for influenza: recommended guidelines for practitioners.

F. Aoki, H. Stiver, U. Allen, 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality.

Charlyn Black, F. Aoki, C. Black, 2003, Canadian journal of public health = Revue canadienne de sante publique.

Immunohistological characterisation of acute herpes simplex virus infection of lumbar dorsal root ganglia in the rat.

F. Aoki, J. Blondeau, J. Nagy, 1993, Journal of medical microbiology.

Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.

F. Aoki, S. Shafran, F. Diaz-Mitoma, 1996, JAMA.

Characteristics of respiratory viral infections during influenza season in Canadian Hutterite Communities

D. Earn, R. Webby, M. Loeb, 2012, Influenza and other respiratory viruses.

Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.

F. Aoki, B. Romanowski, R. Saltzman, 2000, AIDS.

Guidance on the use of antiviral drugs for influenza in acute care facilities in Canada, 2014–2015

F. Aoki, H. Stiver, G. Evans, 2015, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Effects of acetaminophen on adverse effects of influenza vaccination in health care workers.

F. Aoki, M. Cheang, A. Yassi, 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

B Romanowski, H. Kitchener, M. Lehtinen, 2009, The Lancet.

Update on influenza antiviral drug treatment and prophylaxis for the 2015–2016 influenza season

D. Skowronski, F. Aoki, H. Stiver, 2016 .

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

S. Trottier, O. Carewicz, P. Ward, 2000, The Lancet.

Oseltamivir, an Influenza Neuraminidase Inhibitor Drug, Does Not Affect the Steady-State Pharmacokinetic Characteristics of Cyclosporine, Mycophenolate, or Tacrolimus in Adult Renal Transplant Patients

F. Aoki, D. Sitar, J. Jeffery, 2011, Therapeutic drug monitoring.

The Impact of Influenza-associated Respiratory Illnesses on Hospitalizations, Physician Visits, Emergency Room Visits, and Mortality

F. Aoki, C. Black, V. Menec, 2003 .